Label literacy

The Sales Page Names Nothing. The Bottle Names Seven.

This product is regularly described as an undisclosed blend. It is not one. The page selling it names no ingredient, and the bottle arriving in the box carries a complete panel with a milligram figure against every row. Those are two different documents, and only one of them is a disclosure.

By MemoVance Pro Team · Last updated October 29, 2026 · 9 min read · Label literacy · Reviewed by Dr. Joette James, PhD

Three documents, one product

Start by separating what actually exists, because the confusion here is entirely a matter of which piece of paper somebody happens to be looking at.

Three documents about one product, and only the third is the one that governs.

The first is a sales page. Its job is to make a case, and the case it makes is two phrases long: cognitive function and mental clarity. It names no ingredient, no amount and no form.

The third is a Supplement Facts panel. Its job is to state what is in the product, and it does: niacin 7.5 mg NE, calcium 18 mg, L-arginine 200 mg, L-arginine AKG 2:1 extract 200 mg, L-citrulline HCl 100 mg, L-citrulline malate 100 mg and beta-alanine 40 mg. That is 640 mg of amino acids in one capsule, and none of it is pooled into a blend.

A reader who has only met the first document has genuinely been told nothing about the formula. That is where the undisclosed-blend impression comes from, and it is a reasonable inference from incomplete evidence rather than a mistake.

Why a sales page names nothing

There is no mystery in this and it is worth explaining rather than implying something sinister.

A sales page is written to convert. Ingredient names invite comparison, comparison invites arithmetic, and arithmetic is rarely flattering in this category. Leaving the formula off the page removes every one of those steps from the decision.

It is also permitted. Nothing requires a marketing page to reproduce a Supplement Facts panel. The panel has to be on the label of the product itself, where a buyer will find it after the purchase rather than before it.

The result is a sequencing problem rather than a concealment problem. Everything a careful buyer wants is printed; it simply arrives in the box rather than on the screen. Which makes the refund window the mechanism that matters, and the 180 days on this product are what make reading the bottle after ordering a workable strategy rather than a trap.

What a printed panel actually buys you

Every row on the left is possible only because a figure is printed. The right-hand column is not an exaggeration.

That table is the argument of this article compressed into two columns.

Because 200 mg is printed against L-arginine, it can be held against a pooled dose-response analysis that found blood pressure moved at four grams a day and nothing below it. Because the citrulline salts carry 100 mg each, they can be held against a dose ladder in which only three grams twice a day lifted plasma arginine. Because beta-alanine is printed at 40 mg, it can be held against a position stand asking for four to six grams a day.

Every one of those comparisons is unflattering to the product, and every one of them is only possible because the manufacturer printed a number. That is the paradox worth sitting with: the transparency is real, and what it reveals is a set of small amounts.

The calcium row runs the other way. At 18 mg it is far below the 500 to 1,200 mg used in the thyroid interaction studies, so a reader on levothyroxine can dismiss a worry rather than acquire one. A blend would have left that person guessing.

The graphic in the middle

Between the silent sales page and the complete panel sits a third document, and it is the one that settles the question.

The seller publishes an ingredient graphic that names 6 rows: niacin, calcium, L-arginine base, L-arginine AKG 2:1, L-citrulline HCl and L-citrulline malate. Every one appears on the panel, at the amount the panel gives. It stops before beta-alanine, which the bottle carries at 40 mg.

A graphic naming fewer ingredients than the panel is a design decision and nothing more. The failure mode worth worrying about is the opposite one, where marketing names something the regulated document never mentions, and that is not what happens here.

So three sources exist, two of them are marketing, and where they overlap they agree. That is a better outcome than most three-way comparisons in this category produce.

How to see a panel before ordering

The sequencing problem has partial workarounds, and they are worth knowing for any product sold this way rather than only for this one.

1. Look for the panel on a retail page rather than a sales page. Listings frequently photograph the back of the bottle even where the seller's own funnel does not.
2. Ask the desk. A distributor that will not describe the formula over the telephone is telling you something; one that reads the panel out is telling you something better. The number for this product is on the contact page.
3. Read a retailer that reproduces it. This site prints the panel in full, decimal comma included, precisely because the seller's page does not.
4. Check the refund window before you check anything else. Where a formula cannot be seen in advance, the window is what makes the purchase reversible, and its length is the single most important number on the offer.
5. Treat an ingredient graphic as a hint, not an answer. It is artwork. It may be shorter than the panel and it has no obligation to be complete.

The same test on any supplement page

None of this is specific to one brand, and the general version is a useful habit.

When a page sells you an outcome and names no formula, the question to ask is not whether the product is a scam. It usually is not. The question is whether the panel is available anywhere, because a panel that exists and is simply not on the marketing page is a completely different proposition from a panel that pools everything into a blend.

Those two situations look identical from a sales page and are opposites once the bottle arrives. In the first, every claim becomes checkable. In the second, none of them ever will be.

• No ingredients on the page, full panel on the bottle. Sequencing. Everything becomes checkable on delivery, and the refund window is what protects you until then.
• No ingredients on the page, blend total on the bottle. Concealment. Nothing becomes checkable at any point, and the window protects your money but never answers the question.
• Ingredients on the page with no amounts. Half a disclosure. Read the panel before believing the list, because a marketing list is under no obligation to be complete.
• Ingredients and amounts on the page. The best case, and rare. Compare them with the panel on arrival anyway.

This product falls into the first category, which is the better of the two that begin the same way.

What to do when the bottle arrives

Four minutes, on the day the parcel lands, before the first capsule.

Count the rows and confirm there are 7. Add the five amino figures and confirm they come to 640 mg. Read the other-ingredients line, where hypromellose tells you the shell is plant cellulose rather than gelatin. Then compare all of it with the panel printed on this website.

If any of it disagrees, that is what the guarantee is for, and the batch page sets out six checks and the number to call. If all of it agrees, you now know more about this product than the page that sold it to you ever said.

Which is an odd sentence to write on a retail website, and it is the honest description of how this particular product is sold.

References